Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas T Jeker

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Current Opinion in Pharmacology|May 30, 2015
Targeting microRNAs for immunomodulationLukas T Jeker, Romina Marone
Journal of Clinical Immunology|April 16, 2010
Small RNA regulators of T cell-mediated autoimmunityLukas T Jeker, Jeffrey A Bluestone
Immunological Reviews|April 5, 2013
MicroRNA regulation of T-cell differentiation and functionLukas T Jeker, Jeffrey A Bluestone
Journal of Immunology (Baltimore, Md. : 1950)|February 16, 2018
Highly Efficient and Versatile Plasmid-Based Gene Editing in Primary T CellsMara Kornete, Romina Marone, Lukas T Jeker
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2021
Plasmid- or Ribonucleoprotein-Mediated CRISPR/Cas Gene Editing in Primary Murine T CellsMarianne Dölz, Romina Marone, Lukas T Jeker
Cold Spring Harbor Perspectives in Medicine|March 7, 2012
Breakdown in peripheral tolerance in type 1 diabetes in mice and humansLukas T Jeker, Hélène Bour-Jordan, Jeffrey A Bluestone
Immunology Letters|September 3, 2023
Leveraging microRNAs for cellular therapyMarko Hasiuk, Marianne Dölz, Romina Marone, et al.
Plos One|June 7, 2013
DGCR8-mediated production of canonical microRNAs is critical for regulatory T cell function and stabilityLukas T Jeker, Xuyu Zhou, Robert Blelloch, et al.
Immunology Letters|March 31, 2022
CRISPR/Cas-based Human T cell Engineering: Basic Research and Clinical ApplicationBettina E Bernard, Emmanuelle Landmann, Lukas T Jeker, et al.
Hemasphere|July 15, 2021
Sphingosine-1-phosphate Receptor-1 Agonist Averts the De Novo Generation of Autoreactive T-cells in Murine Acute Graft-versus-Host DiseaseMadeleine Vollmer, Philip Smith, Christoph Bucher, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Current Opinion in Pharmacology|May 30, 2015
Targeting microRNAs for immunomodulationLukas T Jeker, Romina Marone
Journal of Clinical Immunology|April 16, 2010
Small RNA regulators of T cell-mediated autoimmunityLukas T Jeker, Jeffrey A Bluestone
Immunological Reviews|April 5, 2013
MicroRNA regulation of T-cell differentiation and functionLukas T Jeker, Jeffrey A Bluestone
Journal of Immunology (Baltimore, Md. : 1950)|February 16, 2018
Highly Efficient and Versatile Plasmid-Based Gene Editing in Primary T CellsMara Kornete, Romina Marone, Lukas T Jeker
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2021
Plasmid- or Ribonucleoprotein-Mediated CRISPR/Cas Gene Editing in Primary Murine T CellsMarianne Dölz, Romina Marone, Lukas T Jeker
Cold Spring Harbor Perspectives in Medicine|March 7, 2012
Breakdown in peripheral tolerance in type 1 diabetes in mice and humansLukas T Jeker, Hélène Bour-Jordan, Jeffrey A Bluestone
Immunology Letters|September 3, 2023
Leveraging microRNAs for cellular therapyMarko Hasiuk, Marianne Dölz, Romina Marone, et al.
Plos One|June 7, 2013
DGCR8-mediated production of canonical microRNAs is critical for regulatory T cell function and stabilityLukas T Jeker, Xuyu Zhou, Robert Blelloch, et al.
Immunology Letters|March 31, 2022
CRISPR/Cas-based Human T cell Engineering: Basic Research and Clinical ApplicationBettina E Bernard, Emmanuelle Landmann, Lukas T Jeker, et al.
Hemasphere|July 15, 2021
Sphingosine-1-phosphate Receptor-1 Agonist Averts the De Novo Generation of Autoreactive T-cells in Murine Acute Graft-versus-Host DiseaseMadeleine Vollmer, Philip Smith, Christoph Bucher, et al.
Pageof 5